Michael Mauro Discusses Therapy-Free CML Remission
17 Visualizzazioni
• 07/29/23
0
0
Incorporare
administrator
Iscritti
Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses stopping chronic myeloid leukemia (CML) treatment for therapy-free remission.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti